The Musk–OpenAI Trial Is a Master Class in How Not to Govern Transformative Technology
The courtroom testimony of Shivon Zilis, delivered this week in San Francisco, reads less like a deposition and more like an org chart of one man's life. She is Neuralink's investment director. She is the mother of four of Elon Musk's children. She served on OpenAI's board from 2020 to 2023. And according to her own account on the stand, Musk once offered her his sperm.
That detail, reported by BBC News on May 6, 2026, is either an irrelevance or the key to everything. In the context of this trial—the second week of Musk's lawsuit against OpenAI over its pivot toward a for-profit structure—it is the key to everything.
A Founder's Board, Run Like a Household
The core dispute in Musk v. Altman et al. is not really about AI safety or the nonprofit mission that OpenAI abandoned. It is about who controls a $100 billion enterprise and by what right. Musk founded OpenAI in 2015 as a counterweight to Google. He资助ed it. He championed it. Then he left the board in 2018, reportedly over a conflict of interest with Tesla's own AI ambitions. Now he wants it back—or at least, he wants a court to compel it to operate as he believes it should.
Zilis's testimony, as reported by France 24 on May 7, adds texture to the power struggle. She stated that Musk wanted Tesla to take over OpenAI. That is not a radical claim—it tracks with what observers have long suspected about Musk's strategic vision for the AI sector. What makes it significant is who is saying it: a woman who was simultaneously Musk's partner, the mother of his children, and a member of the very board she is now describing.
The entanglement is not incidental. It is structural. In technology companies, particularly those governed by nonprofit structures nominally designed to check founder power, boards exist to provide independent oversight. They are supposed to prevent exactly the kind of unilateral capture that Zilis's testimony describes. That she was embedded in Musk's personal life while occupying a seat at OpenAI's decision-making table is not a coincidence of biography. It is a governance failure with a specific design.
The Sperm Offer and the Board Seat
Musk's reported offer of sperm donations to Zilis, who has four children with him, is not merely a personal matter. It is a case study in how power operates at the intersection of intimacy and institutional authority. When a founder extends his biological reach into the lives of board members, the conventional arm's-length assumptions of corporate governance collapse.
This is not a criticism of Zilis personally. It is an observation about the architecture of accountability. A board member who is also a romantic partner—or in this case, a mother of a founder's children—cannot credibly function as a check on that founder's decisions. The conflict of interest is not theoretical. It is lived. And it is precisely the kind of conflict that OpenAI's nonprofit structure was supposed to prevent.
The trial record, as it develops, is revealing a pattern. Musk appears to have treated OpenAI not as an independent institution with its own mandate, but as an extension of his broader portfolio—one to be managed, redirected, or absorbed as his interests dictated. Zilis, from this vantage, was not an independent director. She was a line item in a longer strategy.
The Accountability Problem at the Heart of the AI Race
What the Musk–OpenAI litigation exposes is not unique to this particular dispute. It is the governance problem that sits at the center of the global AI race. OpenAI was designed to be different—a nonprofit counterweight to the commercial incentives that drive other labs. Its structure was supposed to protect it from the very dynamic now playing out in a San Francisco courtroom.
It did not work. Microsoft poured capital into OpenAI, and the nonprofit's independence eroded. The board that failed to check Musk's influence also failed to check that commercial pivot. Zilis's testimony is, in a sense, the residue of that institutional failure—the moment when the personal relationships that masked the governance gap became visible in a legal proceeding.
This matters beyond the parties to the lawsuit. If courts become the primary mechanism for adjudicating the governance of transformative AI companies, something has already gone badly wrong. Legislative and regulatory frameworks have lagged far behind the deployment of systems that will reshape labor, security, and social order. What the public is left with is a founder-versus-foundation dispute in which the real loser may be everyone who will live with the outcome.
The Stakes Are Not Private
The AI systems now being deployed by OpenAI, Anthropic, Google DeepMind, and others do not respect corporate jurisdictional boundaries. They will shape elections, medical diagnoses, criminal sentencing, and military targeting across every country on earth. The governance of those systems—whether it is accountable to independent boards, open-source communities, or democratic institutions—cannot be a private matter between a billionaire and his former partners.
Musk's lawsuit frames itself as a fight for the soul of AI development. But the testimony emerging from the courtroom suggests a narrower contest: a founder who believes he should control an institution he helped create, and a board that eventually pushed back. The public interest in the outcome is real, but it is being litigated in a format designed to resolve private commercial disputes.
What Zilis's testimony clarifies is that the personal and the institutional are not separable in the world Musk built. Neuralink, SpaceX, Tesla, X, and now this lawsuit are not independent ventures. They are nodes in a network of power that runs through personal relationships and legal vehicles alike. That the governance of transformative technology has come to depend on such arrangements is not a scandal. It is a warning.
Monexus covered this trial as a commercial dispute with systemic implications, in contrast to wire outlets that framed it primarily as a personality clash between Musk and Altman.